Arzu Onay Beşikçi (Arzu Onay-Beşikci)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Antiretroviral Therapy

Affordable Care Act

Respiratory Syndrome Coronavirus

Top Venues

Infectious diseases & clinical microbiology

Turkish journal of medical sciences

British journal of pharmacology

Ankara University

University of Alberta (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ankara University

Turkey

Professor :: Pharmacology

Education History

University of Alberta Sep 01 1998 - Jul 14 2003

Canada

PHD :: Pharmacology

Publications

İsmail Çelik, Ezgi Gülten, Arzu Onay Beşikçi, Güle Çınar, İrem Akdemir, Gülgün Kılcıgil, Kemal Osman Memikoğlu, M Serhat Birengel, Alpay Azap
SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir. Infectious diseases & clinical microbiology 4 (3) (2022)
İsmail Çelik, Ezgi Gülten, Arzu Onay Beşikçi, Güle Çınar, İrem Akdemir, Gülgün Kılcıgil, Kemal Osman Memikoğlu, M Serhat Birengel, Alpay Azap
SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir. Infectious diseases & clinical microbiology 4 (3) (2022)
İrem Akdemir, Güle Çınar, Aysel Pehlivanlı, Fatih Ürkmez, İzel Ezgi Topaloğlu, Büşra Akyol, Arzu Onay Beşikçi, Alpay Azap, Kemal Osman Memikoğlu
Pattern of systemic antibiotic use and potential drug interactions: Evaluations through a point prevalence study in Ankara University Hospitals. Turkish journal of medical sciences 51 (2) (2021)
Berna Güven, Zümra Kara, Arzu Onay Beşikçi
Metabolic effects of carvedilol through β-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts. British journal of pharmacology 177 (24) (2020)